Hepatoprotective effect of silymarin on fructose induced nonalcoholic fatty liver disease in male albino wistar rats
Open Access
- 30 March 2021
- journal article
- research article
- Published by Springer Nature in BMC Complementary Medicine and Therapies
- Vol. 21 (1) , 1-13
Abstract
Background: Nonalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease in the Western world, and it’s likely to parallel the increasing prevalence of type 2 diabetes, obesity, and other components of metabolic syndrome. However, optimal treatment for NAFLD has not been established yet. Therefore, this study investigated the hepatoprotective effect of silymarin on fructose-induced nonalcoholic fatty liver disease in rats. Methods: Thirty male Wistar rats were randomly divided into five groups; normal control group that consumed tap water, silymarin control group that consumed tap water and silymarin (400 mg/kg/day), fructose control group that consumed 20% fructose solution, treatment group that consumed 20% fructose solution and silymarin (200 mg/kg/day), and another treatment group that consumed 20% fructose solution and silymarin (400 mg/kg/day). Hepatic triglyceride, serum lipid profile, lipid peroxidation, antioxidant level, morphological features, and histopathological changes were investigated. The data were analyzed using one-way analysis of variance (ANOVA) followed by Tukey multiple comparison test. Statistical significance was determined at p < 0.05. Results: This study showed that the fructose control group had a significantly high value in the stage of steatosis grade, hepatic triglyceride, serum triglyceride, total cholesterol, low-density lipoprotein cholesterol, alanine aminotransferase, aspartate aminotransferase, and hepatic malondialdehyde concentration as compared to the normal control. However, significantly low values of reduced glutathione and plasma total antioxidant capacity were found. The altered parameters due to fructose drastic effect were ameliorated by silymarin treatment. Conclusions: The fructose control group developed dyslipidemia, oxidative stress, and mild steatosis that are the characteristics features of NAFLD. However, silymarin-treated groups showed amelioration in oxidative stress, dyslipidemia, and steatosis.Keywords
This publication has 62 references indexed in Scilit:
- Non-alcoholic fatty liver disease (NAFLD): a tale of fat and sugar?Fibrogenesis & Tissue Repair, 2013
- Melatonin May Curtail the Metabolic Syndrome: Studies on Initial and Fully Established Fructose-Induced Metabolic Syndrome in RatsInternational Journal of Molecular Sciences, 2013
- HDAC inhibitors in experimental liver and kidney fibrosisFibrogenesis & Tissue Repair, 2013
- Improvement of Liquid Fructose-Induced Adipose Tissue Insulin Resistance by Ginger Treatment in Rats Is Associated with Suppression of Adipose Macrophage-Related Proinflammatory CytokinesEvidence-Based Complementary and Alternative Medicine, 2013
- Effects of Metformin, Pioglitazone, and Silymarin Treatment on Non- Alcoholic Fatty Liver Disease: A Randomized Controlled Pilot StudyHepatitis Monthly, 2012
- Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: Analysis of isolated hepatic stellate cellsInternational Journal of Molecular Medicine, 2012
- Antioxidant and Hepatoprotective Effects of Silibinin in a Rat Model of Nonalcoholic SteatohepatitisEvidence-Based Complementary and Alternative Medicine, 2011
- Is the metabolic syndrome caused by a high fructose, and relatively low fat, low cholesterol diet?Archives of Medical Science, 2011
- Blood sample collection in small laboratory animalsJournal of Pharmacology and Pharmacotherapeutics, 2010
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005